Work

Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts).

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.4550

Authors: Samuel Funt, Deaglan Joseph McHugh, Stephanie Tsai, Devon O'Donnell, Andrea Knezevic, Sujata Patil, Deborah Silber, Victor E. Reuter, Joel Sheinfeld, Brett Stewart Carver, Maryann Carousso, Robert J. Motzer, Dean F. Bajorin, George J. Bosl, Darren R. Feldman

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891970417

Cites:

Cited by: 5

Related to: 10